The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: A comparison between child-pugh and model for end-stage liver disease scores

Vascular and Endovascular Surgery

Volumn 47, Issue 4, 2013, Pages 281-287

  Saad, Wael E A ^a   Wagner, Cynthia ^a   Al Osaimi, Abdulla ^a   Bliebel, Wissam ^a   Lippert, Allison ^a   Davies, Mark G ^a   Sabri, Saher S ^a   Turba, Ulku C ^a   Matsumoto, Alan H ^a   Angle, John ^a   Caldwell, Stephen ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

BRTO; gastric varices; MELD score

Indexed keywords

ALBUMIN; BILIRUBIN;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BALLOON OCCLUDED TRANSVENOUS OBLITERATION; BALLOON OCCLUSION; BILIRUBIN BLOOD LEVEL; CHILD PUGH SCORE; CLINICAL ARTICLE; FEMALE; GASTRORENAL SHUNT; HUMAN; HYDROTHORAX; INTERMETHOD COMPARISON; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; RETROSPECTIVE STUDY; SCORING SYSTEM; SHUNTING; STOMACH VARICES;

BRTO; GASTRIC VARICES; MELD SCORE;

ADOLESCENT; ADULT; AGED; ASCITES; BALLOON OCCLUSION; BILIRUBIN; BIOLOGICAL MARKERS; CREATININE; DECISION SUPPORT TECHNIQUES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYDROTHORAX; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878055411     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574413485646     Document Type: Article

References (35)

1. Kamath PS, Kim WR. The Model for end-stage liver disease (MELD). Hepatology. 2007 ; 45 (3). 797-805
2. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 ; 33 (2). 464-470
3. Montgomery A, Ferral H, Vasan R, Postoak DW. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol. 2005 ; 28 (3). 307-312
4. Ferral H, Patel NH. Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedures: current status. J Vasc Interv Radiol. 2005 ; 16 (4). 449-455
5. Saad WE, Darwish WM, Davies MG, Waldman DL. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome. J Vasc Interv Radiol. 2010 ; 21 (2). 218-223
6. Ferral H, Gamboa P, Postoak DW, et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology. 2004 ; 231 (1). 231-236
7. Ferral H, Vasan R, Speeg KV, et al. Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures. J Vasc Interv Radiol. 2002 ; 13 (11). 1103-1108
8. Marroco-Trischitta MM, Kahlberg A, Astore D, Tshiombo G, Mascia D, Chiesa R. Outcome in cirrhotic patients after elective surgical repair of infrarenal aortic aneurysm. J Vasc Surg. 2011 ; 53 (4). 906-911
9. Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study. HPB (Oxford). 2010 ; 12 (3). 174-180
10. Cho HC, Jung HY, Sinn DH, et al. Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD, and MELDNa score. Eur J Gastroenterol Hepatol. 2011 ; 23 (1). 51-59
11. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996 ; 11 (1). 51-58
12. Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y.. Transcatheter oliteration of gastric varices. Part-1. Anatomic classification. Radiographics. 2003 ; 23 (4). 911-920
13. Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter oliteration of gastric varices: part-2. Strategy and techniques based on hemodynamic features. Radiographics. 2003 ; 23 (4). 921-937
14. Kitamoto M, Imamura M, Kamada K, et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol. 2002 ; 178 (5). 1167-1174
15. Ninoi T, Nakamura K, Kaminou T, et al. TIPS versus transcatheter sclerotherapy for gatsric varices. AJR Am J Roentgenol. 2004 ; 183 (2). 369-376
16. Ninoi T, Nishida N, Kaminou T, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol. 2005 ; 184 (4). 1340-1346
17. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Combination treatment of transjugular retrograde obliteration and endoscopic embolization for portosystemic encephalopathy with esophageal varices. Hepatogastroenterology. 2004 ; 51 (59). 1379-1381
18. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery. 2000 ; 129 (4). 414-420
19. Anderson C, Saad WE, Kalagher S, et al. Effect of transjugular intrahepatic portosystemic shunt (TIPS) placement on renal function: a 7-year, single center experience. JVIR J Vasc Interv Radiol. 2010 ; 21 (9). 1370-1376
20. Cho SK, Shin SW, Lee IH, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol. 2007 ; 189 (6). W365 - W372
21. Miyamoto Y, Oho K, Kumamoto M, Toyonaga A, Sata M. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J Gastroenterol Hepatol. 2003 ; 18 (8). 934-942
22. Matsumoto A, Hamamoto N, Nomura T, et al. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices. Am J Gastroenterol. 1999 ; 94 (3). 643-649
23. Kumamoto M, Toyonaga A, Inoue H, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol. 2010 ; 25 (6). 1129-1135
24. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery. 2000 ; 129 (4). 414-420
25. Chikamori F, Kuniyoshi N, Kawashima T, Takase Y. Gastric varices with gastrorenal shunt: combined therapy using transjugular retrograde obliteration and partial splenic embolization. AJR Am J Roengenol. 2008 ; 191 (2). 555-559
26. Sonomura T, Sato M, Kishi K, et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility study. Cardiovasc Intervent Radiol. 1998 ; 21 (1). 27-30
27. Shimoda R, Horiuchi K, Hagiwara S, et al. Short-term complications of balloon-occluded retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts. Abdom Imaging. 2005 ; 30 (3). 306-313
28. Park KS, Kim YH, Choi JS, et al. Therapeutic efficacy of balloon-occluded retrograde transvenous obliteration in patients with gastric variceal bleeding. Korean J Gastroenterol. 2006 ; 47 (5). 370-378
29. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. JVIR J Vasc Interv Radiol. 2001 ; 12 (3). 327-336
30. Sabri SS, Swee W, Turba UC, et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration (BRTO) utilizing sodium tetradecyl sulfate foam. JVIR J Vasc Interv Radiol. 2011 ; 22 (3). 309-316
31. Chikamori F, Kuniyoshi N, Kawashima T, Takase Y. Gastric varices with gastrorenal shunt: combined therapy using transjugular retrograde obliteration and partial splenic embolization. AJR Am J Roengenol. 2008 ; 191 (2). 555-559
32. Park SJ, Chung JW, Kim H-C, Jae HJ, Park JH. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. JVIR J Vasc Intervent Radiol. 2010 ; 21 (4). 503-507
33. Akahoshi T, Hashizume M, Tomikawa M, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. Gastroenterology. 2008 ; 23 (11). 1702-1709
34. Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology. 1999 ; 211 (2). 349-356
35. Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T. Infusion of 50% glucose solution before injection of ethanolamine oleate during balloon-occluded retrograde transvenous obliteration. Australas Radiol. 2007 ; 51 (4). 334-338